ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00884468
Recruitment Status : Completed
First Posted : April 20, 2009
Last Update Posted : May 27, 2009
Sponsor:
Information provided by:
Wyeth is now a wholly owned subsidiary of Pfizer

Brief Summary:
This is an epidemiological non-interventional study assessing the prevalence of anxiety and/or depression disorders in patients suffering from Psoriatic Arthritis (PsA) in Spain.

Condition or disease
Psoriatic Arthritis

Study Type : Observational
Actual Enrollment : 384 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Anxiety and Depression in Patients With Psoriatic Arthritis: Prevalence and Characteristics
Study Start Date : May 2008
Actual Primary Completion Date : December 2008
Actual Study Completion Date : December 2008


Group/Cohort
1
Patients with PsA that fulfill the eligibility criteria of the study



Primary Outcome Measures :
  1. Prevalence of anxiety and/or depression disorders in patients suffering from PsA in Spain as measured by the Hospital Anxiety and Depression Scale (HAD) [ Time Frame: 12 months ]

Secondary Outcome Measures :
  1. To assess the relation between the PsA severity and the presence of anxiety and/or depression disorders in patients suffering from PsA in Spain. [ Time Frame: 12 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with PsA from outpatient's surgery or primary health care centres
Criteria

Inclusion criteria:

  • Patients both genders over 18 years old
  • Patients with PsA diagnosis

Exclusion criteria:

  • Patients with PsA that suffer from other rheumatologic diseases or non-concomitant rheumatologic diseases that the investigator considers not to be appropriate for the study.
  • Patients with any medical or physical condition (cognitive damage or difficulties for understanding) that create difficulties for reading and completing the questionnaires described in the protocol.
  • Patients that in the study period are taking part in another clinical trial.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00884468


Locations
Spain
Reus, Tarragona, Spain, 43201
Sponsors and Collaborators
Wyeth is now a wholly owned subsidiary of Pfizer
Investigators
Study Director: Medical Monitor Wyeth is now a wholly owned subsidiary of Pfizer

Responsible Party: Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth
ClinicalTrials.gov Identifier: NCT00884468     History of Changes
Other Study ID Numbers: 0881A5-4468
First Posted: April 20, 2009    Key Record Dates
Last Update Posted: May 27, 2009
Last Verified: May 2009

Keywords provided by Wyeth is now a wholly owned subsidiary of Pfizer:
Anxiety and depression in patients with psoriatic arthritis

Additional relevant MeSH terms:
Depression
Arthritis
Arthritis, Psoriatic
Behavioral Symptoms
Joint Diseases
Musculoskeletal Diseases
Spondylarthropathies
Spondylarthritis
Spondylitis
Spinal Diseases
Bone Diseases
Psoriasis
Skin Diseases, Papulosquamous
Skin Diseases